BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26457819)

  • 21. Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14ARF.
    Lang JC; Borchers J; Danahey D; Smith S; Stover DG; Agrawal A; Malone JP; Schuller DE; Weghorst CM; Holinga AJ; Lingam K; Patel CR; Esham B
    Int J Oncol; 2002 Aug; 21(2):401-8. PubMed ID: 12118338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions.
    Klump B; Hsieh CJ; Nehls O; Dette S; Holzmann K; Kiesslich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
    Br J Cancer; 2003 Jan; 88(2):217-22. PubMed ID: 12610506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic changes in the CDKN2A locus are associated with differential expression of P16INK4A and P14ARF in HPV-positive oropharyngeal squamous cell carcinoma.
    Schlecht NF; Ben-Dayan M; Anayannis N; Lleras RA; Thomas C; Wang Y; Smith RV; Burk RD; Harris TM; Childs G; Ow TJ; Prystowsky MB; Belbin TJ
    Cancer Med; 2015 Mar; 4(3):342-53. PubMed ID: 25619363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma.
    Ishida E; Nakamura M; Ikuta M; Shimada K; Matsuyoshi S; Kirita T; Konishi N
    Oral Oncol; 2005 Jul; 41(6):614-22. PubMed ID: 15975525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.
    Sharma G; Mirza S; Prasad CP; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Apr; 80(20):1873-81. PubMed ID: 17383681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
    Zhang C; Guo X; Zhang L; Lu Z; Ma N; Cheng Y; Shen F; Zhang B; Wu M; Wei L
    J Surg Oncol; 2008 Nov; 98(6):462-8. PubMed ID: 18683194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.
    Kiss NB; Geli J; Lundberg F; Avci C; Velazquez-Fernandez D; Hashemi J; Weber G; Höög A; Ekström TJ; Bäckdahl M; Larsson C
    Endocr Relat Cancer; 2008 Jun; 15(2):609-21. PubMed ID: 18509008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
    Sailasree R; Abhilash A; Sathyan KM; Nalinakumari KR; Thomas S; Kannan S
    Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):414-20. PubMed ID: 18268126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines.
    Nagy E; Veress G; Szarka K; Csoma E; Beck Z
    Anticancer Res; 2005; 25(3B):2153-60. PubMed ID: 16158958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel frameshift mutation in the p16/INK4A tumor suppressor gene in canine breast cancer alters expression from the p16/INK4A/p14ARF locus.
    Lutful Kabir FM; Agarwal P; Deinnocentes P; Zaman J; Bird AC; Bird RC
    J Cell Biochem; 2013 Jan; 114(1):56-66. PubMed ID: 22833492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma.
    Su PF; Lee TC; Lin PJ; Lee PH; Jeng YM; Chen CH; Liang JD; Chiou LL; Huang GT; Lee HS
    Int J Cancer; 2007 Sep; 121(6):1257-64. PubMed ID: 17534893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter methylation of INK4a/ARF as detected in bile-significance for the differential diagnosis in biliary disease.
    Klump B; Hsieh CJ; Dette S; Holzmann K; Kiebetalich R; Jung M; Sinn U; Ortner M; Porschen R; Gregor M
    Clin Cancer Res; 2003 May; 9(5):1773-8. PubMed ID: 12738733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MBD2-mediated transcriptional repression of the p14ARF tumor suppressor gene in human colon cancer cells.
    Martin V; Jørgensen HF; Chaubert AS; Berger J; Barr H; Shaw P; Bird A; Chaubert P
    Pathobiology; 2008; 75(5):281-7. PubMed ID: 18931530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.